Stock comparison
Avantor, Inc. is 1.3x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($10.16 B vs $8.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AVTR is larger
Avantor, Inc. is 1.3x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($10.16 B vs $8.09 B).
Market value leader
AVTR
Avantor, Inc. is 1.3x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($10.16 B vs $8.09 B).
Revenue leader
AVTR
BIO: $2.58B vs AVTR: $6.55B.
Profit leader
BIO
BIO: $759.90M vs AVTR: -$530.20M.
Margin leader
BIO
BIO: 29.4% vs AVTR: -8.1% net margin.
| Metric | BIO | AVTR |
|---|---|---|
| Market cap | $8.09 B | $10.16 B |
| US-listed rank | #1080 | #935 |
| Revenue (latest FY) | $2.58B | $6.55B |
| Net income (latest FY) | $759.90M | -$530.20M |
| Net margin | 29.4% | -8.1% |
| P/E (trailing FY) | 10.6x | - |
| SEC filings | 1,494 | 765 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Avantor, Inc. is 1.3x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($10.16 B vs $8.09 B).
In their latest fiscal years, Bio-Rad Laboratories, Inc. reported $2.58B in revenue while Avantor, Inc. reported $6.55B.
Full pages: Bio-Rad Laboratories, Inc. and Avantor, Inc., or browse the full rankings.